Dominika Deborska-Materkowska
Overview
Explore the profile of Dominika Deborska-Materkowska including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
112
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Halloran P, Madill-Thomsen K, Bohmig G, Bromberg J, Budde K, Barner M, et al.
Am J Transplant
. 2024 Aug;
25(1):72-87.
PMID: 39117038
Most kidney transplant patients who undergo biopsies are classified as having no rejection based on consensus thresholds. However, we hypothesized that because these patients have normal adaptive immune systems, T...
2.
Cieslik A, Burban A, Gniewkiewicz M, Gozdowska J, Deborska-Materkowska D, Perkowska-Ptasinska A, et al.
Transplant Proc
. 2023 Oct;
55(9):2053-2057.
PMID: 37778932
Background: Protocol biopsies are performed to detect subclinical pathologies that may lead to future graft dysfunction. However, they are not routinely performed interventions in every transplant center. There is no...
3.
Gniewkiewicz M, Gozdowska J, Deborska-Materkowska D, Czerwinska K, Perkowska-Ptasinska A, Burban A, et al.
Immun Inflamm Dis
. 2023 Jun;
11(6):e901.
PMID: 37382267
Background: Chemokines (chemotactic cytokines) are small proteins which are engaged in many pathophysiological processes, including inflammation and homeostasis. In recent years, application of chemokines in transplant medicine was intensively studied....
4.
Deborska-Materkowska D, Perkowska-Ptasinska A, Sadowska-Jakubowicz A, Pazik J, Serwanska-Swietek M, Mikolajczyk N, et al.
Pol Arch Intern Med
. 2022 Aug;
133(1).
PMID: 36018060
Introduction: The risk of polyomavirus‑associated nephropathy (PyVAN) currently ranges from 1% to 10%, and the risk of graft loss is 10% to 50% within 2 years post‑diagnosis. There is currently...
5.
Barbachowska A, Gozdowska J, Piotrowska-Kownacka D, Sawicka M, Deborska-Materkowska D, Skolimowska E, et al.
Ann Transplant
. 2022 Aug;
27:e935874.
PMID: 35941813
BACKGROUND COVID-19 disease, caused by the SARS-CoV-2 virus, has been one of the greatest challenges in modern medicine. It is mostly known to affect the pulmonary system, leading to pneumonia...
6.
Kaminska D, Deborska-Materkowska D, Koscielska-Kasprzak K, Mazanowska O, Remiorz A, Poznanski P, et al.
Vaccines (Basel)
. 2022 Jul;
10(7).
PMID: 35891232
The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is associated with a robust immune response. The development of systemic inflammation leads to a...
7.
Deborska-Materkowska D, Kaminska D
Viruses
. 2021 Sep;
13(9).
PMID: 34578460
Since its outbreak in December 2019, the coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), led to an enormous rise in scientific response with...
8.
Kowalewska J, Moudden I, Perkowska-Ptasinska A, Kapp M, Fogo A, Lin M, et al.
Transpl Int
. 2021 Aug;
34(11):2286-2296.
PMID: 34339576
Polyomavirus associated nephropathy (PyVAN) continues to be a burden in renal transplantation leading to allograft insufficiency or graft failure. A presumptive diagnosis of PyVAN is made based on the presence...
9.
Gniewkiewicz M, Paszkowska I, Gozdowska J, Czerwinska K, Sadowska-Jakubowicz A, Deborska-Materkowska D, et al.
Diagnostics (Basel)
. 2020 Feb;
10(2).
PMID: 32092939
Chronic renal allograft dysfunction (CAD) is a major limiting factor of long-term graft survival. The hallmarks of progressive CAD are interstitial fibrosis and tubular atrophy (IFTA). MicroRNAs are small, regulatory...
10.
Gniewkiewicz M, Czerwinska M, Gozdowska J, Czerwinska K, Sadowska A, Deborska-Materkowska D, et al.
Pol Arch Intern Med
. 2019 Aug;
129(9):592-597.
PMID: 31389404
Introduction: Early prognostic markers that identify high‑risk kidney transplant recipients may lead to optimization of immunosuppressive therapy and improved long‑term outcomes. Objectives: The aim of this study was to assess...